Skip to main content
Caplight Logo









EvolVeritas Biotechnology Ltd.

EvolVeritas Biotechnology Ltd.

Private
BudapestHealthcare & Life Scienceshttps://evolveritas.com/

Last Round

Grant

Mar 22, 2022

Total Funding Raised

$943,700

Company Overview

EvolVeritas Biotechnology Ltd. is a biotechnology company that develops drug compounds through the development of specific protein molecules for therapeutic areas such as ischemic reperfusion injury, thrombosis, and COVID-19.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

directed protein evolutionphage display platformdrug candidate developmentstructure-driven protein engineeringischemia-reperfusion injuryMASP-2 inhibitorbiologics discoverytherapeutic proteinpreclinical biotechdrug licensingviral infection therapeuticsresearch tool ligandsbiotech spinoffrecombinant protein productionIgA nephropathy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

EvolVeritas Biotechnology Ltd. Comparables

Compare EvolVeritas Biotechnology Ltd. with similar companies based on industry and business-model similarity.

EvolVeritas Biotechnology Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Transcenta Holding
76%
KeyMed Biosciences
73%
RevolKa Ltd.
72%

EvolVeritas Biotechnology Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMar 22, 2022

EvolVeritas Biotechnology Ltd. Investors

Notable investors and investment history

EvolVeritas Biotechnology Ltd. investors
InvestorRounds
PBG FMC Venture Capital Fund ManagementSeed
National Research, Development and Innovation OfficeGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 22, 2022

    $922K grant from National Research, Development and Innovation Office.

EvolVeritas Biotechnology Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

EvolVeritas Biotechnology Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about EvolVeritas Biotechnology Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersBudapest
Year Founded2011
Last FundingMar 22, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?